L
Luke Bereznicki
Researcher at University of Tasmania
Publications - 154
Citations - 2473
Luke Bereznicki is an academic researcher from University of Tasmania. The author has contributed to research in topics: Medicine & Pharmacist. The author has an hindex of 23, co-authored 134 publications receiving 1836 citations.
Papers
More filters
Journal ArticleDOI
Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis.
TL;DR: The threshold for optimal adherence to achieve better virologic outcomes appears to be wider than the commonly used cut-off point (≥95% adherence), which could be redefined to a slightly lower level to encourage the prescribing ART at an early stage of HIV infection.
Journal ArticleDOI
Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
Woldesellassie M. Bezabhe,Leanne Chalmers,Luke Bereznicki,Gregory M. Peterson,Mekides A. Bimirew,Desalew M. Kassie +5 more
TL;DR: Economic constraints, perceived stigma and discrimination, fasting, holy water, medication side effects, and dissatisfaction with healthcare services were major reasons for patients being non-adherent and lost to follow-up.
Journal ArticleDOI
Hospitalization in older patients due to adverse drug reactions - The need for a prediction tool
Nibu Parameswaran Nair,Leanne Chalmers,Gregory M. Peterson,Bonnie J Bereznicki,Ronald L. Castelino,Luke Bereznicki +5 more
TL;DR: There is a clear need to investigate the utility of tools to identify high-risk patients to target appropriate interventions toward prevention of ADR-related hospital admissions, and the cost-effectiveness of such strategies would be necessary to target them to those older individuals who are at highest risk of ADRs.
Journal ArticleDOI
Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors
TL;DR: The majority of ADR-related hospitalisations in adults in developed and developing countries were preventable in both settings, highlighting the importance of improving medication use, particularly in vulnerable patient groups such as the elderly, patients with multiple comorbidities and, in developing countries, Patients with HIV/AIDS.
Journal ArticleDOI
Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring
Luke Bereznicki,Shane L Jackson,Gregory M. Peterson,EC Jeffrey,Katherine Marsden,David M. L. Jupe +5 more
TL;DR: In the hands of patients the CoaguChek XS showed good correlation with laboratory determination of INR and compared well with expanded and narrow clinical agreement criteria.